Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
Open | $0.83 |
Close | $0.83 |
Volume / Avg. | 74.46K / 98.98K |
Day Range | 0.80 - 0.84 |
52 Wk Range | 0.74 - 1.76 |
Market Cap | $34.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 0.04% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).
There is no analysis for Achilles Therapeutics.
Achilles Therapeutics has a consensus price target of $2.83.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $0.8121 last updated July 23, 2024 at 7:03 PM EDT.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.